文献速递胃肠外科肝胆胰外科急腹症与外科感染

肝硬化患者择期与急诊腹部手术术后死亡率和并发症发生率及危险因素

Incidence and Risk Factors of Postoperative Mortality and Morbidity After Elective Versus Emergent Abdominal Surgery in a National Sample of 8193 Patients With Cirrhosis.
PubMed 文献 · Ann Surg · 2021-01-01

该研究基于VA外科质量改进项目2001至2017年前瞻性数据,分析8193例肝硬化患者及非肝硬化对照组腹部手术后的结局,发现肝硬化患者30天死亡率显著高于慢性乙肝和无肝病对照组,急诊手术死亡率约为择期手术的6倍,MELD评分≥10者 mortality 差异最大。

要点

  • 肝硬化患者腹部手术后30天死亡率显著高于慢性乙肝和无肝病患者
  • 急诊手术术后死亡率约为择期手术的6倍
  • 择期手术中结直肠切除死亡率最高,腹股沟疝修补最低

核心结论

  • 肝硬化患者腹部手术后死亡率显著高于无肝硬化患者,且急诊手术死亡率远高于择期手术。
  • 准确的术前风险评估应综合考虑肝硬化严重程度、合并症、手术类型及急诊与否。

研究设计与样本

  • 前瞻性收集VA外科质量改进项目2001至2017年数据,纳入8193例肝硬化患者、864例慢性乙肝非肝硬化对照和5468例无慢性肝病对照,均接受腹部手术。
  • 采用随机效应模型控制潜在混杂因素进行分析。

主要发现

  • 肝硬化患者30天死亡率为4.4%,显著高于慢性乙肝对照的1.3%(aOR 2.80,95%CI 1.57-4.98)和无肝病对照的0.8%(aOR 4.68,95%CI 3.27-6.69)。
  • MELD评分≥10的患者中死亡率差异最大。
  • 肝硬化患者急诊手术后死亡率为17.2%,择期手术后为2.1%(aOR 5.82,95%CI 4.66-7.27)。
  • 择期手术中,结直肠切除术后30天死亡率最高(7.0%),腹股沟疝修补最低(0.6%)。
  • 术后死亡预测因素包括高MELD评分、低血清白蛋白、腹水、肝性脑病、急诊手术、手术类型、术中输血、COPD、癌症、脓毒症、呼吸机依赖、功能状态及年龄。

临床怎么用

  • 术前应评估肝硬化严重程度(如MELD评分)、合并症及手术类型,尤其关注急诊手术的高风险。
  • 对MELD评分≥10的肝硬化患者,应充分告知术后死亡风险并优化围术期管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the incidence and risk factors for mortality and morbidity in patients with cirrhosis undergoing elective or emergent abdominal surgeries. BACKGROUND: Postoperative morbidity and mortality are higher in patients with cirrhosis; variation by surgical procedure type and cirrhosis severity remain unclear. METHODS: We analyzed prospectively-collected data from the Veterans Affairs (VA) Surgical Quality Improvement Program for 8193 patients with cirrhosis, 864 noncirrhotic controls with chronic hepatitis B infection, and 5468 noncirrhotic controls without chronic liver disease, who underwent abdominal surgery from 2001 to 2017. Data were analyzed using random-effects models controlling for potential confounders. RESULTS: Patients with cirrhosis had significantly higher 30-day mortality than noncirrhotic patients with chronic hepatitis B [4.4% vs 1.3%, adjusted odds ratio (aOR) 2.80, 95% confidence interval (CI) 1.57-4.98] or with no chronic liver disease (0.8%, aOR 4.68, 95% CI 3.27-6.69); mortality difference was highest in patients with Model for End-stage Liver Disease (MELD) score ≥10. Among patients with cirrhosis, postoperative mortality was almost 6 times higher after emergent rather than elective surgery (17.2% vs. 2.1%, aOR 5.82, 95% CI 4.66-7.27). For elective surgeries, 30-day mortality was highest after colorectal resection (7.0%) and lowest after inguinal hernia repair (0.6%). Predictors of postoperative mortality included cirrhosis-related characteristics (high MELD score, low serum albumin, ascites, encephalopathy), surgery-related characteristics (emergent vs elective, type of surgery, intraoperative blood transfusion), comorbidities (chronic obstructive pulmonary disease, cancer, sepsis, ventilator dependence, functional status), and age. CONCLUSIONS: Accurate preoperative risk assessments in patients with cirrhosis should account for cirrhosis severity, comorbidities, type of procedure, and whether the procedure is emergent versus elective.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Johnson KM, Newman KL, Green PK, et al. Incidence and Risk Factors of Postoperative Mortality and Morbidity After Elective Versus Emergent Abdominal Surgery in a National Sample of 8193 Patients With Cirrhosis. Ann Surg. 2021. PMID: 31714310. doi:10.1097/SLA.0000000000003674

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。